Search

Your search keyword '"Kicic A"' showing total 147 results

Search Constraints

Start Over You searched for: Author "Kicic A" Remove constraint Author: "Kicic A" Database MEDLINE Remove constraint Database: MEDLINE
147 results on '"Kicic A"'

Search Results

1. Phage cocktail amikacin combination as a potential therapy for bacteremia associated with carbapenemase producing colistin resistant Klebsiella pneumoniae.

2. Lentiviral vector gene therapy and CFTR modulators show comparable effectiveness in cystic fibrosis rat airway models.

3. Real world effectiveness of early ensitrelvir treatment in patients with SARS-CoV-2, a retrospective case series.

4. Phage therapy to treat cystic fibrosis Burkholderia cepacia complex lung infections: perspectives and challenges.

5. Community-based mpox and sexually transmitted disease surveillance using discarded condoms in the global south.

6. Real time monitoring of respiratory viral infections in cohort studies using a smartphone app.

7. The respiratory health effects of acute in vivo diesel and biodiesel exhaust in a mouse model.

8. Transcriptomic analysis of primary nasal epithelial cells reveals altered interferon signalling in preterm birth survivors at one year of age.

9. Current and novel therapies for management of Acinetobacter baumannii -associated pneumonia.

10. Antenatal creatine supplementation reduces persistent fetal lung inflammation and oxidative stress in an ovine model of chorioamnionitis.

11. Exploring the Complexity of the Human Respiratory Virome through an In Silico Analysis of Shotgun Metagenomic Data Retrieved from Public Repositories.

12. Wastewater-based epidemiological surveillance of SARS-CoV-2 new variants BA.2.86 and offspring JN.1 in South and Southeast Asia.

13. Increased faecal shedding in SARS-CoV-2 variants BA.2.86 and JN.1.

14. Airway epithelium respiratory illnesses and allergy (AERIAL) birth cohort: study protocol.

15. Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial.

16. Exploring indoor and outdoor dust as a potential tool for detection and monitoring of COVID-19 transmission.

17. Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infection.

18. Terminal Deuterium Atoms Protect Silicon from Oxidation.

19. Tracing the transmission of mpox through wastewater surveillance in Southeast Asia.

20. Stability Considerations for Bacteriophages in Liquid Formulations Designed for Nebulization.

21. COVID-19 monitoring with sparse sampling of sewered and non-sewered wastewater in urban and rural communities.

22. Ca-EDTA restores the activity of ceftazidime-avibactam or aztreonam against carbapenemase-producing Klebsiella pneumoniae infections.

23. Defining the pediatric response to SARS-CoV-2 variants.

24. Pulmonary bacteriophage and cystic fibrosis airway mucus: friends or foes?

25. Airway Epithelium Respiratory Illnesses and Allergy (AERIAL) birth cohort: study protocol.

26. Respiratory Health Effects of In Vivo Sub-Chronic Diesel and Biodiesel Exhaust Exposure.

27. Multiple traces of monkeypox detected in non-sewered wastewater with sparse sampling from a densely populated metropolitan area in Asia.

28. Phage Therapy as an Alternative Treatment Modality for Resistant Staphylococcus aureus Infections.

29. Biodiesel feedstock determines exhaust toxicity in 20% biodiesel: 80% mineral diesel blends.

30. Complete Genomes of Three Pseudomonas aeruginosa Bacteriophages, Kara-mokiny 1, Kara-mokiny 2, and Kara-mokiny 3.

31. Genome Sequence of a Lytic Staphylococcus aureus Bacteriophage Isolated from Breast Milk.

33. Complete Genome Sequences of Four Pseudomonas aeruginosa Bacteriophages: Kara-mokiny 8, Kara-mokiny 13, Kara-mokiny 16, and Boorn-mokiny 1.

34. Bacteriophage: A new therapeutic player to combat neutrophilic inflammation in chronic airway diseases.

35. Living with lung disease: experimental models to assess the long-term effects of prematurity.

36. Macrophage PD-1 associates with neutrophilia and reduced bacterial killing in early cystic fibrosis airway disease.

37. Biodiesel Exhaust Toxicity with and without Diethylene Glycol Dimethyl Ether Fuel Additive in Primary Airway Epithelial Cells Grown at the Air-Liquid Interface.

38. Ancestral SARS-CoV-2, but not Omicron, replicates less efficiently in primary pediatric nasal epithelial cells.

39. Toxicity of different biodiesel exhausts in primary human airway epithelial cells grown at air-liquid interface.

40. High prevalence of mgrB-mediated colistin resistance among carbapenem-resistant Klebsiella pneumoniae is associated with biofilm formation, and can be overcome by colistin-EDTA combination therapy.

41. AI-Driven Cell Tracking to Enable High-Throughput Drug Screening Targeting Airway Epithelial Repair for Children with Asthma.

42. Pseudomonas aeruginosa modulates neutrophil granule exocytosis in an in vitro model of airway infection.

43. Exacerbation of chronic cigarette-smoke induced lung disease by rhinovirus in mice.

44. Investigating the Implications of CFTR Exon Skipping Using a Cftr Exon 9 Deleted Mouse Model.

45. SLC6A14 Impacts Cystic Fibrosis Lung Disease Severity via mTOR and Epithelial Repair Modulation.

46. Primary Nasal Epithelial Cells as a Surrogate Cell Culture Model for Type-II Alveolar Cells to Study ABCA-3 Deficiency.

47. Dysregulated Notch Signaling in the Airway Epithelium of Children with Wheeze.

48. Viral Induced Effects on a Vulnerable Epithelium; Lessons Learned From Paediatric Asthma and Eosinophilic Oesophagitis.

49. Changes in airway inflammation with pseudomonas eradication in early cystic fibrosis.

50. Development and validation of a miniaturized bacteriophage host range screening assay against antibiotic resistant Pseudomonas aeruginosa.

Catalog

Books, media, physical & digital resources